Skip to main content
. 2022 May 24;12:8694. doi: 10.1038/s41598-022-12797-y

Table 1.

Treatment choices and treatment outcomes.

UCD MCD Total
Treatment, n (%) 33 (50.8%) 32 (49.2%) 65
SE 31 (93.9%) 15 (46.9%) 46 (70.8%)
SE + RT 0 1 (3.1%) 1 (1.5%)
SE + CT 2 (6.1%) 16 (50.0%) 18 (27.7%)
Follow-up time (months), median, n (%) 53.0, 33 (50.8%) 79.5, 32 (49.2%) 66.0, 65
Recurrence, n (%) 0 2 (6.3%) 2 (3.1%)
Survival, n (%) 33 (100%) 29 (90.6%) 62 (95.4%)

SE surgical excision, RT radiotherapy, CT chemotherapy.